Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 390-392

  Schilling, Claudia ^a   Blum, Werner F ^b   Heuser, Isabella ^a,c   Paslakis, Georgios ^a   Wudy, Stefan A ^d   Deuschle, Michael ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOXEPIN; FLUOXETINE; SOMATOMEDIN C; VENLAFAXINE;

ADULT; AGED; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HAMILTON SCALE; HUMAN; LETTER; LUMBAR PUNCTURE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PSYCHOPHARMACOTHERAPY; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 79955574728     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182189d86     Document Type: Letter

References (15)

1. Schneider HJ, Pagotto U, Stalla GK. Central effects of the somatotropic system. Eur J Endocrinol. 2003;149: 377-392. (Pubitemid 37461517)
2. Rupprecht R, Rupprecht C, Rupprecht M, et al. Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression. J Affect Disord. 1989;17:9-16. (Pubitemid 19125725)
3. Deuschle M, Blum WF, Strasburger CJ, et al. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology. 1997;22: 493-503. (Pubitemid 27505109)
4. Weber-Hamann B, Blum WF, Kratzsch J, et al. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry. 2009;42:23-28.
5. Bezchlibnyk YB, Xu L, Wang JF, et al. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res. 2007;1147: 213-217. (Pubitemid 46574546)
6. Duman CH, Schlesinger L, Terwilliger R, et al. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res. 2009;198:366-371.
7. Malberg JE, Platt B, Rizzo SJ, et al. Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology. 2007;32:2360-2368. (Pubitemid 47587671)
8. Trejo JL, Llorens-Martín MV, Torres-Alemán I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci. 2008;37:402-411.
9. Chen MJ, Russo-Neustadt AA. Running exerciseY and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent. Growth Factors. 2007;25:118-131. (Pubitemid 47487579)
10. Ding Q, Vaynman S, Akhavan M, et al. Insulin-like growth factor I interfaces with brain-derived neurotrophic factorYmediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience. 2006;140:82.
11. Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005;1037:204-208. (Pubitemid 40362398)
12. Hoshaw BA, Hill TI, Crowley JJ, et al. Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. Eur J Pharmacol. 2008;594:109-116.
13. Wada A. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci. 2009;110:14-28.
14. Heinze E, Böker M, Blum W, et al. GH, IGF-I, IGBP-3 and IGFBP-2 in cerebrospinal fluid of infants, during puberty and in adults. Exp Clin Endocrinol Diabetes. 1998;144: 197-202. (Pubitemid 28356611)
15. Engesser-Cesar C, Anderson AJ, Cotman CW. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience. 2007;144:1033-1044. (Pubitemid 46013977)